tiprankstipranks
Advertisement
Advertisement

MDCX Stock Latest News

Medicus Pharma price target lowered to 90c from $1 at Alliance Global
The FlyMedicus Pharma price target lowered to 90c from $1 at Alliance Global
6d ago
MDCX
Medicus Pharma reports Q2 EPS (21c) vs (43c) last year
PremiumThe Fly
Medicus Pharma reports Q2 EPS (21c) vs (43c) last year
7d ago
MDCX
Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk
PremiumCompany Announcements
Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk
11d ago
MDCX
Medicus Pharma Teverelix granted investigational new drug authorization in UAE
PremiumThe Fly
Medicus Pharma Teverelix granted investigational new drug authorization in UAE
24d ago
MDCX
Medicus Pharma initiated with a Buy at Alliance Global
PremiumThe Fly
Medicus Pharma initiated with a Buy at Alliance Global
27d ago
MDCX
Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study
PremiumThe FlyMedicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study
27d ago
MDCX
Medicus Pharma receives FDA feedback, IRB approval for Teverelix study
Premium
The Fly
Medicus Pharma receives FDA feedback, IRB approval for Teverelix study
1M ago
MDCX
Medicus submits SkinJect Rare Pediatric Disease Designation request to FDA
Premium
The Fly
Medicus submits SkinJect Rare Pediatric Disease Designation request to FDA
2M ago
MDCX
Medicus Pharma submits substantial modification application through EU CTIS
PremiumThe Fly
Medicus Pharma submits substantial modification application through EU CTIS
3M ago
MDCX
Medicus Pharma Shareholders Approve Auditor, Board and Consolidation
PremiumCompany Announcements
Medicus Pharma Shareholders Approve Auditor, Board and Consolidation
3M ago
8K
MDCX
Medicus Pharma submits Protocol SKNJCT-005 to the FDA
PremiumThe Fly
Medicus Pharma submits Protocol SKNJCT-005 to the FDA
3M ago
MDCX
Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure
PremiumCompany Announcements
Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure
3M ago
8K
MDCX
Medicus Pharma reports Q1 EPS (31c), consensus (22c)
PremiumThe FlyMedicus Pharma reports Q1 EPS (31c), consensus (22c)
3M ago
MDCX
Medicus Pharma announces results from Phase 2 SKNJCT-003 analysis
Premium
The Fly
Medicus Pharma announces results from Phase 2 SKNJCT-003 analysis
4M ago
MDCX
Medicus Pharma meets with lawmakers to support SkinJect designations
Premium
The Fly
Medicus Pharma meets with lawmakers to support SkinJect designations
4M ago
MDCX
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
PremiumRatings
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
4M ago
MDCX
Medicus Pharma Expands ATM Equity Program for Funding
PremiumCompany Announcements
Medicus Pharma Expands ATM Equity Program for Funding
4M ago
8K
MDCX
Medicus Pharma initiated with a Buy at Roth Capital
PremiumThe Fly
Medicus Pharma initiated with a Buy at Roth Capital
4M ago
MDCX
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
PremiumThe Fly
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
4M ago
MDCX
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
PremiumCompany AnnouncementsMedicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
4M ago
MDCX
Medicus Pharma enters media partnership with New to The Street
Premium
The Fly
Medicus Pharma enters media partnership with New to The Street
5M ago
MDCX
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
Premium
Company Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
5M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >